Advances in Animal-Free Manufacturing of Biopharmaceuticals - New recombinant raw ingredients developed for use in large-scale mammalian cell culture are becoming readily available. - BioPharm

ADVERTISEMENT

Advances in Animal-Free Manufacturing of Biopharmaceuticals
New recombinant raw ingredients developed for use in large-scale mammalian cell culture are becoming readily available.


BioPharm International


2. Committee for Proprietary Medicinal Products (CPMP). CPMP position statement on new variant CJD and plasma-derived medicinal products. London (UK): European Agency for the Evaluation of Medicinal Products; 1998 Feb 25.

3. Zoon K. To manufacturers of biological products. Letter. Rockville (MD): Dept. of Health and Human Services (US), Center for Biologics Evaluation and Research; 2003 Apr 19.

4. European Medicines Agency (EMEA). Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMEA/410/01). Revised. London (UK): EMEA; 2003 Oct 2.

5. Jayme DW, Blackman KE. Culture media for propagation of mammalian cells, viruses, and other biologicals. Adv Biotech Processes 1985;5:1-30.

6. Kan M, Yamane I. In vitro proliferation and lifespan of human diploid fibroblast in serum free BSA containing medium. J Cell Phys 1982;111:155-62.

7. Froud SJ. The development, benefits and disadvantages of serum-free media [review]. Dev Biol Stand 1999;99:157-66.

8. Morris AE, Schmid J. Effects of insulin and LONG® R3 on serum-free Chinese hamster ovary cell cultures expressing two recombinant proteins. Biotechnol Prog 2000 Sep-Oct;16(5):693-7.

9. Sunstrom NA, Gay RD, Wong DC, Kitchen NA, DeBoer L, Gray PP. Insulin-like growth factor-I and transferrin mediate growth and survival of Chinese hamster ovary cells. Biotechnol Prog 2000 Sep-Oct;16(5):698-702.

10. Iglesias J, Abernethy VE, Wang Z, Lieberthal W, Koh JS, Levine JS. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol Renal Physiol 1999;277: F711-22.

11. Yandell CA, Lawson J, Butler I, Wade B, Sheehan A, Grosvenor S, et al. An analog of IGF-I, a potent substitute for insulin in serum-free manufacture of biologics by CHO cells. Bioprocess Int 2004 Mar;2(3):6-64.

12. Voorhamme D, Yandell CA. LONGĖR_IGF-I as a more potent alternative to insulin in serum-free culture of HEK293 cells. Molecular Biotech 2006;34:201-4.

13. Sargent PJ, Farnaud S, Cammack R, Zoller HMP, Evans RW. BioMetals 2006 Oct;19(5):513-9.

14. Emerson TE Jr. Unique features of albumin: a brief review. Crit Care Med 1989; Jul;17(7):690-4.

15. Tarelli E, Mire-Sluis A, Tivnann HA, Bolgiano B, Crane DT, Gee C, et al. Recombinant human albumin as a stabilizer for biological materials and for the preparation of international reference reagents. Biologicals 1998 Dec;26(4):331-46.

16. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982;298:347-50.

17. Hollenberg CP, Gellissen G. Production of recombinant proteins by methylotrophic yeasts. Current Opinion in Biotech 1997 Oct;8(5):554-60.

18. Cereghino GPL, Cregg JM. Applications of yeast in biotechnology: protein production and genetic analysis. Current Opinion in Biotech 1999 Oct;10 (5):422-7.

19. Sleep D, Belfield GP, Balance DJ, Steven J, Jones S, Evans LR, et al. Saccharomyces cerevisiae strains that overexpress heterologous proteins. Biotech 1991;9:183-7.

20. Sleep D, Finnis C, Evans, L. Enhanced protein expression through strain selection, gene disruption, improved vector design and co-expression of endogenous chaperones. Microbial Cell Fact 2006;5(Suppl 1):S29.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here